Skip to main content
Clinical Trials/IRCT138707201166N2
IRCT138707201166N2
Completed
Phase 2

Assessment of the efficacy of the combination of a silver-containing dressing with intralesional meglumine antimoniate injections in comparison with a combination of an inert dressing and intralesional meglumine antimoniate injections and intralesional meglumine antimoniate injections alone in the treatment of cutaneous leishmaniasis due to Leishmania major: A randomized assessor-blind controlled clinical trial

Tehran University of Medical Sciences0 sites210 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cutaneous leishmaniasis.
Sponsor
Tehran University of Medical Sciences
Enrollment
210
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • a) Parasitollogically proven cases of cutaneous leishmaniasis based on positive smear and/or culture b) Otherwise healthy subjects on the basis of medical history c)Age: 12\-60 years d) willing to participate in the study and sign the informed consent (by the patient or his/her/partner/guardian) in case of younger than 18 years Exclusion criteria: a) Pregnant or lactating women b) Duration of lesions more than 3 months c) Number of lesions more than 5 d) Ulcer size greater than 5 cm in the largest diameter e) History of full course of standard treatment (antimonials) f) History of allergy to meglumine antimoniate or silver g) Serious systemic illnesses as judged by the physician h) Participation in any drug trial in the last 60 days i) Indication for administration of systemic treatment with meglumine antimoniate j) Presence of secondary bacterial infection of the lesion according to clinical appearance of the lesion

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials